What a 40% rise in coupling-reagent prices does to a 2 mg vial
Follow the resin, not the catalogue.
TheCompound Journal
Reporting on incretins, compounding & the peptide supply chain
Page 24 of 27 of this archive, newest first.
Follow the resin, not the catalogue.
The route did not close because of a rule about peptides.
Follow the resin, not the catalogue.
Reported from the analysis, not from a warning notice.
The route did not close because of a rule about peptides.
Follow the resin, not the catalogue.
The absence of microbiological capability in this market is a commercial fact with a straightforward explanation, and it is worth understanding before blaming anybody for it.
The route did not close because of a rule about peptides.
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
The route did not close because of a rule about peptides.
Reported from the analysis, not from a warning notice.
Follow the resin, not the catalogue.
The route did not close because of a rule about peptides.
Follow the resin, not the catalogue.
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
Reported from the analysis, not from a warning notice.
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
Every degradation pathway accelerates by orders of magnitude on reconstitution, because the solvent that lyophilisation removed is the reagent most of them need.
Reported from the analysis, not from a warning notice.
Follow the resin, not the catalogue.